Se Won Oh

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Clinical implications of pathologic diagnosis and classification for diabetic nephropathy

Se Won Oh, Sejoong Kim, Ki Young Na et al. · Diabetes Research and Clinical Practice · 2012 · 167 citations

Glomerular Disease, Glomerulonephritis, Clinical Implications +12

Intestinal microbiota control acute kidney injury severity by immune modulation

Jihyun Yang, Chan Johng Kim, Yoon Sook Ko et al. · Kidney International · 2020 · 130 citations

Inflammation, Dysbiosis, Mucosal Immunology +11

Intestinal barrier disruption and dysregulated mucosal immunity contribute to kidney fibrosis in chronic kidney disease

Jihyun Yang, Sung Yoon Lim, Yoon Sook Ko et al. · Nephrology Dialysis Transplantation · 2018 · 111 citations